John W. Babich
President bij Ratio Therapeutics, Inc.
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Jack Hoppin | M | - |
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | - |
Allan M. Green | M | 79 |
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | - |
Susan K. Whoriskey | F | - |
Ratio Therapeutics, Inc.
Ratio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ratio Therapeutics, Inc. is a pharmaceutical company based in the United States. The company is based in Boston, MA. The company's mission is to accelerate the development of next-generation precision radiopharmaceuticals for solid tumors and transform oncology treatment paradigms. The company's fully integrated proprietary R&D platforms, Trillium™ and Macropa™, enable the imaging, discovery, and advancement of novel radiopharmaceuticals that have first/best-in-class delivery, safety, and efficacy properties. Founded by John Babich, Ph.D., and Jack Hoppin, Ph.D., the company employs a growing team of radiopharmaceuticals discovery and development experts with backgrounds in the life science industry. The CEO of the company is Jack William Hoppin. | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 3 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- John W. Babich
- Persoonlijk netwerk